(Q52978477)

English

Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth.

scientific article published on 31 December 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

1 reference

based on heuristic

inferred from title

author name string

Jenni A Tamminen

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

Miao Yin

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

Mikko Rönty

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

Eva Sutinen

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

Arja Pasternack

5

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

Olli Ritvos

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

Marjukka Myllärniemi

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

Katri Koli

8

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

language of work or name

0 references

publication date

31 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

332

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

102-115

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Finnish Institute of Occupational Health (FIOH): prevention and detection of asbestos-related diseases, 1987-2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Malignant pleural mesothelioma: medical treatment update

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Activins and inhibins and their signaling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

The bright and the dark sides of activin in wound healing and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

The activins and their binding protein, follistatin-Diagnostic and therapeutic targets in inflammatory disease and fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

New insights into the mechanisms of activin action and inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Differential actions of follistatin and follistatin-like 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Signaling of transforming growth factor-beta family members through Smad proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Activin B can signal through both ALK4 and ALK7 in gonadotrope cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Activin isoforms signal through type I receptor serine/threonine kinase ALK7

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Non-Smad TGF-beta signals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1/2 and deactivating p38 MAP kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Activin B promotes epithelial wound healing in vivo through RhoA-JNK signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Activin B Promotes BMSC-Mediated Cutaneous Wound Healing by Regulating Cell Migration via the JNK-ERK Signaling Pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Beta A versus beta B: is it merely a matter of expression?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Asbestos exposure induces alveolar epithelial cell plasticity through MAPK/Erk signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Activin-A overexpression in the murine lung causes pathology that simulates acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Beyond TGFβ: roles of other TGFβ superfamily members in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Role of transforming growth factor-beta signaling in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

TGF-β signalling and its role in cancer progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Mysteries of TGF-β Paradox in Benign and Malignant Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Nodal signalling in embryogenesis and tumourigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Cadherins, catenins and APC in pleural malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Molecular pathogenesis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Regulation of cell proliferation by Smad proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

A role for the mitogen-activated protein kinase kinase kinase 1 in epithelial wound healing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Transcriptional regulation of the cyclin D1 gene at a glance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Phosphorylated extracellular signal-regulated kinases are significantly increased in malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Nonamplified FGFR1 is a growth driver in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Hypoxia-activated Smad3-specific dephosphorylation by PP2A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.12.010

7 January 2021

Identifiers

10.1016/J.YEXCR.2014.12.010

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/25557874

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52978477&oldid=1370655631"